Abstract: A vehicle body structure includes a side sill formed of high strength steel and a seat cross-member formed of high strength steel. A floor pan is welded to at least one of the side sill and the seat cross-member. A flange includes a base extending from the seat cross-member and a tab extending from the base. The tab is spaced from the seat cross-member and is welded to the floor pan and the side sill.

Abstract: A deflector member comprises opposing first and second walls and a plurality of sidewalls arranged adjacent to each other and between the first and second walls, the sidewalls having a cross-sectional shape between the first and second walls that is at least three-sided. The deflector member is adapted to mount to a vehicle frame. The deflector member is further adapted to extend distally from the first wall to the second wall relative to the vehicle frame, and away from a centerline of the vehicle frame.

Abstract: A deflector member comprises opposing first and second walls and a plurality of sidewalls arranged adjacent to each other and between the first and second walls, the sidewalls having a cross-sectional shape between the first and second walls that is at least three-sided. The deflector member is adapted to mount to a vehicle frame. The deflector member is further adapted to extend distally from the first wall to the second wall relative to the vehicle frame, and away from a centerline of the vehicle frame.

Abstract: An organic light emitting device having a phase-separated light-emissive layer comprising: a charge transport phase comprising a charge transport material; and an emitting phase, the emitting phase comprising a plurality of discrete emissive domains dispersed in the charge transport phase, each emitting domain comprising a host material and one or more metal complexes for emitting light by phosphorescence; wherein the charge transport material has a T1 energy level lower than the T1 energy level of the metal complexes and the host material has a T1 energy level higher than the T1 energy level of the metal complexes.

Abstract: A system for treating a fluid in a container. The system includes an included airlift tube and active air input into the tube. The air is supplied by a pump that is external to the tank and sized in accordance with the size of the tank. The system is arranged to promote the generation of suspended growth bacteria. The bacteria are provided by an air supply that is diffused in the tube wherein the air carries naturally occurring bacterial spores. The airlift tube includes one or more inlet ports located below an air diffuser. The tube may be located on the floor of the tank, suspended from the ceiling of the tank or arranged to float within the tank. A plurality of tubes may be used together to treat fluids in containers larger than standard septic tanks. A pH neutralizing device may form part of the system.

Abstract: A local device, such as a field-programmable gate array, has a local state machine and a local interface component for communicating with a remote device that implements a remote state machine. The local interface component receives a new set of incoming data from the remote device and determines whether the new set is good data or bad data. If good data, then the local interface component causes the new set of data to transmitted internally for use by the local state machine. If bad data, then the local interface component does not forward the new set of data to the local state machine, which instead continues to use a previously received set of good data. Although the clock rate of the local and remote state machines may differ from the frame rate of the local interface component, their operations are nevertheless synchronized.

Abstract: A V shape bumper extension for a vehicle is provided where the V shape member has an extension member and a support member. The extension member extends linearly away from a bumper and the support member is positioned at an acute angle with respect to a crush can. The support member includes an outer edge spaced apart from the crush can and is connected to the crush can through at least one breakable attachment.

Abstract: A system for treating a fluid in a container. The system includes an included airlift tube and active air input into the tube. The air is supplied by a pump that is external to the tank and sized in accordance with the size of the tank. The system is arranged to promote the generation of suspended growth bacteria. The bacteria are provided by an air supply that is diffused in the tube wherein the air carries naturally occurring bacterial spores. The airlift tube includes one or more inlet ports located below an air diffuser. The tube may be located on the floor of the tank, suspended from the ceiling of the tank or arranged to float within the tank. A plurality of tubes may be used together to treat fluids in containers larger than standard septic tanks. A pH neutralizing device may form part of the system.

Abstract: An approach is provided for providing uniform content management for a user equipment. A uniform content management platform determines new content from a plurality of content of different categories. The uniform content management platform further initiates presentation of the new content via a graphical user interface that includes: a dashboard providing a layout of the new content, a content manager that is invoked upon selection of a particular one of the new content for managing a group of content of a common category, and a content editor that is invoked upon selection of one of the content in the group for editing the selected content.

Abstract: A frangible vehicle sub-frame joint between a sub-frame and compartment pan. The sub-frame defines a clearance area forward of a collar. In a collision event, the collar is separated into a breakaway portion and a portion that is retained by the sub-frame. The breakaway portion breaks into a clearance area defined in front of the frame joint when the sub-frame is subjected to a front end impact.

Abstract: A frangible vehicle sub-frame joint between a sub-frame and compartment pan. The sub-frame defines a clearance area forward of a collar. In a collision event, the collar is separated into a breakaway portion and a portion that is retained by the sub-frame. The breakaway portion breaks into a clearance area defined in front of the frame joint when the sub-frame is subjected to a front end impact.

Abstract: A spread spectrum slip time encoding scheme encodes data values with one or more Pseudo Noise (PN) codes and generates a corresponding PN encoded data stream. Other data values are encoded into the PN encoded data stream by varying a slip time between the 10 encoded data values.

Abstract: The invention relates to pyridine-pyridinone derivatives general formula (I): in which R1, R2, R3, R4, n, n?, V, W, Y, Z, Ar are as defined in the description, and to their methods of preparation and their therapeutic applications.

Abstract: This invention relates to novel compounds of formula (I). Formula (I) in which the variable groups are as defined in the specification and claims, to pharmaceutical compositions containing them, and to a method of treatment using them for treatment of cancer.

Abstract: Novel compounds of structure Formula I: or an enantiomer, a diastereomer, or a pharmaceutically acceptable salt thereof, wherein n1, R1, R2, R3 and R4 are defined herein, are provided which are GPR119 G protein-coupled receptor modulators. GPR119 G protein-coupled receptor modulators are useful in treating, preventing, or slowing the progression of diseases requiring GPR119 G protein-coupled receptor modulator therapy. Thus, the disclosure also concerns compositions comprising these novel compounds and methods of treating diseases or conditions related to the activity of the GPR119 G protein-coupled receptor by using any of these novel compounds or a composition comprising any of such novel compounds.

Abstract: This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

Abstract: An organic light emitting device having a phase-separated light-emissive layer comprising: a charge transport phase comprising a charge transport material; and an emitting phase, the emitting phase comprising a plurality of discrete emissive domains dispersed in the charge transport phase, each emitting domain comprising a host material and one or more metal complexes for emitting light by phosphorescence; wherein the charge transport material has a T1 energy level lower than the T1 energy level of the metal complexes and the host material has a T1 energy level higher than the T1 energy level of the metal complexes.

Abstract: This invention relates to novel pyrrozolotriazine compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients.

Abstract: This invention relates to novel compounds of formula (I). Formula (I) in which the variable groups are as defined in the specification and claims, to pharmaceutical compositions containing them, and to a method of treatment using them for treatment of cancer.

Abstract: An organic light emitting device having a phase-separated light-emissive layer comprising: a charge transport phase comprising a charge transport material; and an emitting phase, the emitting phase comprising a plurality of discrete emissive domains dispersed in the charge transport phase, each emitting domain comprising a host material and one or more metal complexes for emitting light by phosphorescence; wherein the charge transport material has a T1 energy level lower than the T1 energy level of the metal complexes and the host material has a T1 energy level higher than the T1 energy level of the metal complexes.